Proteome-wide Mendelian randomization study implicates inflammaging biomarkers in retinal vasculature, cardiometabolic diseases and longevity

Ana Villaplana-Velasco, Nicolas Perrot, Yu Hang, Michael Chong, Emanuele Trucco, Walter Nelson, Jeremy Petch, Hertzel Gerstein, Raina Parminder, Salim Yusuf, Miguel Bernabeu, Albert Tenesa, Konrad Rawlik, Guillaume Pare, Alexander Doney, Erola Pairo-Castineira, Marie Pigeyre
doi: https://doi.org/10.1101/2024.07.13.24310153

Abstract

With the increasing proportion of elderly individuals, improving understanding of the biological mechanisms involved in healthy aging is of utmost importance. Retinal vascular complexity obtained from retinal fundus photographs, and evaluated as fractal dimension (ie, Df), a measure of the geometric pattern of the retinal vasculature, has recently emerged as a valuable indicator of diseases and aging processes. The purpose of our study was to elucidate possible mechanisms underlying those relationships. By integrating retinal Dfwith genomic and plasma proteome biomarkers, we uncovered novel pathways involved in determining Df and its links with cardiometabolic diseases and longevity. First, we performed a genome wide association study (GWAS) of retinal vascular Df by meta-analysing signals from 74,434 participants from three large epidemiological cohorts, the Canadian Longitudinal Study of Aging (CLSA), the Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS), and the UK Biobank (UKBB). We replicated four known loci associated with Df, and identified one novel locus within or near DAAM1, as well as found seven suggestive associations within or near CSNK1A1L, MAST4, HIVEP1, LOC283038, FNDC3A, SP100, and SUGP1 genes. GWAS summary statistics confirmed a negative correlation between Df and cardiovascular disease, stroke, and inflammation, but a positive correlation with longevity. Next, employing Mendelian randomization which combined genetic determinants of Df, and cis-protein Quantitative Trait Loci from 1,159 circulating proteins from the Prospective Urban and Rural Epidemiological (PURE) cohort (n=12,066), we identified eight causal mediators for Df, namely IgG Fc receptorIIb, BST1, LILRB2, IL16, MMP12, PON2, ALPP, and PDL2. Notably, MMP12 and IgG Fc receptorIIb have been suggested to connect Df to cardiometabolic outcomes (i.e., coronary artery disease, stroke, peripheral artery disease, and type 2 diabetes) and longevity, respectively. Pathway enrichment analyses highlighted the role of IgG Fc receptorIIb in immune and inflammatory responses to aging processes, referred to as inflammaging. This multi-pronged approach unveils IgG Fc recIIb and MMP12 as key mediators in immune and inflammation pathways, linking lower Df to a higher risk of cardiometabolic diseases and a shorter lifespan. Therefore, retinal Df may be a convenient way to estimate inflammaging, such that lower retinal Df, may indicate a higher inflammaging status. Targeting MMP12 and IgG Fc ReceptorIIb may promote healthy aging and mitigating the occurrence of cardiometabolic diseases in the elderly population.

Understand the biological pathways that influence healthy aging has become a public health priority 1. Aging is associated with an incremental loss of complexity in the dynamics of many physiological systems, rendering them less resilient to environmental stresses 2. This loss of resilience progressively increases the vulnerability to late-onset diseases, disability, frailty, and ultimately leads to the death 3. Thus, a biomarker signature for “systemic complexity” could potentially provide an indicator of global system resilience.

The retinal vasculature offers a conveniently accessed and imaged perspective on the circulatory system of the human body, providing valuable insights not only into the vascular health of the retina itself but also of other organs 4. The automated quantification of density and overall complexity of the retinal vasculature from retinal photographs—achieved through the measurement of its vascular fractal dimension (abbreviated as Df), with a higher value reflecting a more complex branching pattern—offers a powerful tool in this regard 5. Early evidence suggested that aging-related changes in the retinal vasculature result in a decrease of the Df measures 6. More recently, research has provided compelling evidence that reduced retinal vascular Df is a risk factor for various age-related diseases, including hypertension, type 2 diabetes, coronary artery disease, stroke, and cognitive decline 5,7. Those findings underscore the clinical significance of assessing retinal vasculature complexity through its Df, as a valuable indicator of aging-related vascular changes. However, the biomolecular mechanisms underlying the relationship between retinal Df and the occurrence of age-related diseases remain largely unknown.

We explored the innovative concept of employing Df as an indicator of aging, enabling the causal biomolecular links between aging and cardiometabolic health to be explored. We aimed to uncover novel pathways involved in aging processes by combining Df measures with high-throughput genetic and plasma proteome biomarkers. Specifically, we leveraged genetic factors influencing Dfto explore the causal connections between microvascular complexity, circulating protein levels, and cardiometabolic outcomes and longevity using Mendelian randomization (MR) 8.

In our comprehensive multimodal approach, we conducted a large genome-wide association study (GWAS) meta-analysis on retinal Df from three expansive epidemiological cohorts, namely the Canadian Longitudinal Study of Ageing (CLSA), the Genetics of Diabetes Audit and Research Tayside Study (GoDARTS), and the UK Biobank (UKBB). We next performed a proteome-wide Mendelian randomization (MR) analysis, which combined genetic determinants of Df, with greater than one thousand circulating protein biomarkers from individuals enrolled in the Prospective Urban and Rural Epidemiological (PURE) study. This approach allowed us to pinpoint candidate biomarkers for Df, and investigated whether such biomarkers are also involved in the links between Dfand cardiometabolic diseases and longevity. Then, we conducted pathway enrichment analyses to provide a deeper understanding of the interactions in which the identified biomarkers are involved within the systemic molecular network (Figure 1). Collectively, our study indicated critical pathways and mechanisms, and provided insights to promote healthy aging and longevity. This study also informed on new therapeutic targets to mitigate cardiometabolic diseases.

Figure 1:
Figure 1:

Study design

Results

Genome-wide association study meta-analysis identified eight novel loci associated with retinal fractal dimension

We performed GWAS meta-analysis for retinal Df from 74,434 individuals of European ancestry who participated in CLSA, GoDARTS or UKBB cohorts. The retinal fundus images available from all individuals in those cohorts were processed by the automatic VAMPIRE software to compute Df, as previously described elsewhere 9. The demographic characteristics of each cohort are summarized in Suppl Tables 1-3. First, we conducted the GWAS by fitting a linear model with polygenic effect adjustment in each cohort separately. We then performed an inverse-variance weighted meta-analysis of the GWAS results. The quantile-quantile plot showed an adequate control of genomic inflation λGC = 1.065 (Suppl Figure 1). The meta-analysis revealed five independent genome-wide significant associations (at P-Value < 10-8) (Figure 2, Table 1), including one novel locus and four replicated loci reported in previous GWASs of retinal Df 5,10. The novel association corresponded to an intronic variant located on chromosome 14 (rs2295848, P-Value = 1.41 x 10-9) in the DAAM1 gene, which has been previously related to brain imaging phenotypes 11,12,13,14. Two of the replicated loci were close to HERC2 (rs12913832, P-Value = 2.34 x 10-59) and OCA2 (rs35717941, P-Value = 1.20 x 10-11), two genes on chromosome 15 that has previously been associated with retinal Df, pigmentation, and several eye conditions, including cataract, visual acuity or retinal vessel tortuosity 14,15,16 Additionally, two other genetic variants near SLC45A2 on chromosome 5 (5:33956560, P-Value = 7.58 x 10-9) and SLC12A9 on chromosome 7 (rs80308281, P-Value = 1.51 x 10-10) were associated with retinal Df, both genes being related to hair pigmentation 17,18. The SLC12A9 lead variant has also been reported to be associated with arterial blood pressure and resting heart rate 19.

Figure 2:
Figure 2: Manhattan Plot of the GWAS meta-analysis (CLSA-GODARTS-UKB) for Df.

Points are truncated at –log10(P)=20 for clarity. Bold gene names indicate novel significant and suggestive associations.

View this table:
Table 1.

GWAS meta-analysis results

In addition to these genomic regions, we found seven suggestive associations (at P-Value < 10-6), including an intergenic variant near CSNK1A1L located on chromosome 13 (rs1937758, P-Value = 7.94 x 10-8); an insertion at MAST4 located on chromosome 5 (rs34212425, P-Value = 6.76 x 10-7), which has previously been associated with hypertension and coronary artery disease 20,21,22; a locus in a regulatory region on chromosome 6 (rs142448155, P-Value = 1.00 x 10-6) that is close to HIVEP1, which is a gene related to inflammation and immunity 23; a variant in LOC283038 on chromosome 10 (rs144937719, P-Value = 7.41 x 10-8); a variant in FNDC3A, located on chromosome 13 (rs11839094, P-Value = 4.78 x 10-7), which has been associated with chronic autoimmune inflammatory diseases 24; a variant at SP100 on chromosome 2 (rs1180388, P-Value = 1.99 x 10-7), for which the gene may play a role in angiogenesis and viral infection 25,26; and a variant in SUGP1 on chromosome 19 (rs1212184373, P-Value = 2.39 x 10-7), a gene associated with cholesterol concentration and coronary artery disease 27,28. No significant heterogeneity was found between cohorts, except for the variants located in the HERC2/OCA2 gene (Heterogeneity P-value = 5.79 x 10-96). Those loci were significantly associated with Df in the UKBB and CLSA, but with a stronger effect in the UKBB (Suppl Figure 2).

Subsequent gene-level analysis of GWAS using the Multi-marker Analysis of GenoMic Annotation (MAGMA)29 tool, showed an enrichment of significant genes in pathways related to melanin biosynthesis and inflammatory response (Suppl. Tables 4,5). Finally, we estimated the genetic correlations of Df with systemic inflammation and cardiometabolic outcomes. We found nominally significant negative correlations of Df with C-reactive protein (rg = -0.13 ± 0.05), atherosclerosis (rg = -0.24 ± 0.03), coronary artery disease (rg = -0.12 ± 0.06), stroke (rg = -0.23 ± 0.09), and a positive correlation with longevity (rg = 0.12 ± 0.06) (Suppl Table 6). Such findings were consistent with the findings that we previously reported for analysis conducted in a subset of UKBB individuals 10.

Mendelian Randomization and colocalization demonstrate causal associations for immune and inflammatory biomarkers with retinal fractal dimension

We screened a panel of 1,159 plasma biomarkers involved in inflammation and cardiometabolic pathways 30 for putative causal associations with Df using a two-sample bidirectional MR analysis. A subset of 264 biomarkers had suitable genetic instruments to be retained in the forward MR, including circulating biomarkers as exposures, and retinal Df as outcome. We found evidence of an association between genetically-predicted biomarker concentrations and Df for eight of those biomarkers beyond the Bonferroni-corrected significance threshold (at P-Value < 0.05/264). Genetically-determined circulating levels of IgG Fc recIIb, BST1, LILRB2, IL16, MMP12, and PON2 were positively associated with Df, while genetically-determined circulating levels of ALPP and PDL2 were negatively associated with Df (Figure 3A, Suppl Table 7). When stratifying analyses according to diabetes status, associations for LILRB2, MMP12, PON2, and ALPP were consistent, while additional positive associations for TCN2 levels, and negative associations for MATN3, TMPRSS5, and UNC5C with Df were observed in individuals without diabetes (P-Value < 0.05/136) (Suppl Table 8). Positive associations of FCN2, SERPINA9, DDC, IL2RA, and LGMN, and negative associations of C1QA, NCAM, and CRTAM levels were also observed with Df in individuals with diabetes (P-Value < 0.05/244) (Suppl Table 9).

Figure 3:
Figure 3:

MR and colocalization of biomarkers associated with Df.

A. Volcano plot of circulating biomarkers associated with Df, identified by MR.

B. Colocalization of FCGR2B with Df.

Using a total of 1,159 unique biomarkers, a reverse MR analysis, using Dfas exposure and biomarkers as outcomes, was used to rule out a reverse causation of Df on circulating biomarker levels. Although, this analysis did not reveal significant associations between genetically-determined Df measures and biomarkers (P-Value < 0.05/1,159 = < 4.3 ×10-5), the most significant association was a negative relationship between Dfand FOXO3, such that FOXO3 circulating levels decreased by 12.27 (+/-3.21) SD per 1 SD increase in genetically-determined Df (P-Value = 1.35×10-4) (Suppl Table 10). This is noteworthy given that FOXO3 has an established role in longevity 31 and vascular aging 32.

Phenome-wide Mendelian Randomization revealed that three biomarkers associated with retinal fractal dimension are also shared with cardiometabolic outcomes and longevity

We conducted a phenome-wide MR to investigate the associations of retinal Df and biomarkers related to Df, with a broad range of cardiometabolic outcomes, encompassing 71 phenotypes for which the GWAS summary statistics were extracted from publicly available consortium data. First, phenome-wide MR of Df on cardiometabolic outcomes showed significant inverse relationships with estimated glomerular filtration rate (P-Value < 0.05/71) (Suppl Table 11). Next, among the eight Df-related biomarkers, three were also significantly associated with cardiometabolic disease phenotypes (P-value < 0.05/(8*71)). Higher genetically-predicted IgG Fc recIIb levels were associated with longer parental lifespan (mean change of 0.02 (+/-0.003) year per 1 SD increase in biomarker level; P-Value = 5.5 x 10-7) and decreased LDL-Cholesterol levels (mean change of -0.01 (+/-0.002) mmol/L per 1 SD increase in biomarker level; P-Value=1.24 x 10-5). Higher MMP12 levels were associated with a lower risk of stroke (OR per 1 SD increase in biomarker level, 0.92; 95%CI 0.90-0.95; P-Value = 5.96 x 10-11), and in particular, with stroke of ischemic cause (OR, 0.91; 95%CI 0.89-0.94); P-Value = 6.90 x 10-9), as well as with a lower risk of peripheral artery disease (OR, 0.86; 95%CI 0.83-0.90; P-Value = 1.55 x 10-13), type 2 diabetes (OR, 0.95; 95%CI 0.93-0.97; P-Value = 1.65 x 10-5), and coronary artery disease (OR, 0.92; 95%CI 0.87-0.96; P-Value = 1.28×10-4). Higher LILRB2 levels were associated with lower HDL-cholesterol levels (mean change of -0.06, +/-0.008 mmol/L; P-Value = 6.43 x 10-13) and higher triglycerides levels (0.02, +/-0.004 mmol/L; P-Value = 3.14 x 10-7) (Figure 4; Suppl Table 12).

Figure 4:
Figure 4:

Heatmap of the associations between significant biomarkers for Df and cardiometabolic disease outcomes.

Multivariate MR investigating the effects of the identified biomarkers on diseases, adjusted for their effects on Df, confirmed that the effects of IgG Fc recIIb on longevity were partially mediated by an effect on Df, with an attenuation of the effect of IgG Fc recIIb on longevity by 34% when adjusting on Df (Dfadjusted mean change of 0.01 (+/-0.002) year per 1 SD increase in biomarker level; P-Value = 3.31 x 10-12). The effects of MMP12 levels on cardiometabolic outcomes were also partially mediated by its effects on Df, but to a lesser extent (ranging from 9% to 15% of effect attenuation after adjustment on Df) (Suppl Table 13).

Moreover, colocalization analysis confirmed that circulating IgG Fc recIIb levels (encoded by FCGR2B gene) and retinal Df shared a common causal genetic variant with a posterior probability superior to 80% (i.e., H3+H4≥0.8) (Figure 3B, Suppl Table 14). To investigate which cells might drive this FCGR2B protein Quantitative Trait Locus (pQTL) association, we conducted further colocalization analyses between FCGR2B pQTL and single-cell expression quantitative trait loci (sc-eQTL) in peripheral blood mononuclear cells (PMBCs)33. This supported the presence of the causal variant effect in FCGR2B across different cell types, and most of which were involved in the immune response (Suppl Table 15, Suppl Figure 3).

Network analysis of biomarkers confirms enrichment for immune and inflammatory pathways

We reinforced the MR findings with protein-protein interaction networks, which revealed significant enrichment for pathways involved in immune and inflammatory responses, such as cytokine-cytokine receptor interaction pathway (False Discovery Rate (FDR) = 4.12×10-5), and immune-related disease (FDR = 0.015) (Figure 5, Suppl Tables 16,17). We also investigated the expression levels and chromatin activity of the Df -associated biomarkers in the retinal tissue. Out of the eight MR significant biomarkers, three (IgG Fc recIIb, PON2, and IL16) were expressed in retinal tissue and associated with open chromatin regions and related to immune and metabolic networks (Suppl Table 18) 34.

Figure 5:
Figure 5:

Network analysis of associated biomarkers (P-value <0.001) from MR results using the UKB and CLSA cohorts.

Discussion

To the best of our knowledge, this study is the largest GWAS meta-analysis for retinal Df to date. We identified eight novel loci associated with Df, and replicated the associations of four previously identified variants 5,10. We also confirmed genetic correlations between Df and systemic inflammation, cardiovascular disease, stroke and longevity, and identified circulating MMP12 and IgG Fc recIIb levels as key mediators linking Df to cardiometabolic and longevity outcomes. Notably, enrichment analyses also highlighted the role of IgG Fc recIIb in immune and inflammatory responses to aging, processes referred to as inflammaging. Finally, reverse MR suggested that circulating FOXO3 levels may be a blood biomarker for changes in retinal vascular Df.

The findings from the Df GWAS meta-analysis were consistent with previous genetic analyses on retinal Df, thus, supporting the biologically coherent relationships of Df - associated variants with various ocular and cardiovascular traits and diseases 5,10,35. Interestingly, we found that several loci were also associated with either cardiovascular risk factors (e.g., hypertension, and dyslipidaemia) or diseases (e.g., coronary artery diseases), as well as inflammatory and immune responses20,21,22,23,24,25,26,27,28.

Previous studies focused on the links between Df and diseases, and showed that a lower Df was associated with a higher risk of mortality, incident hypertension, congestive heart failure, renal failure, type 2 diabetes, sleep apnea, anemia, and multiple ocular conditions, and was causally associated with skin cancer and retinal detachment 5,10. However, none of those studies investigated the molecular mechanisms linking Df to such diseases. Our study is the first MR analysis investigating the relationships between the proteome and Df, and provides novel evidence on the role of eight circulating biomarkers with changes in Df, including IgG Fc recIIb, BST1, LILRB2, IL16, MMP12, PON2, ALPP, and PDL2. Additionally, we investigated the associations between those eight biomarkers and health-related traits. Notably, IgG Fc recIIb and MMP12 also emerged as causal mediators of diseases, linking Df to longevity and to various chronic diseases, including stroke, peripheral artery disease, and type 2 diabetes, respectively. The IgG Fc recIIb effect size on lifespan was in the range of previously reported biomarkers for longevity 36. The MR findings were reinforced by single-cell colocalization analysis in PMBCs, which confirmed the putative causal role of IgG Fc RecIIb on Df changes driven by its expression in immune cells; and by enrichment analysis that indicated that IgG Fc RecIIb expression was associated with different regions of the retinal regulatory network.

Biologically, IgG Fc RecIIb is a densely expressed receptor that plays a role in the immune response and antiviral activity of malt cells, basophils, eosinophils, macrophages, monocytes, dendritic cells, and B cells in the spleen and lymph nodes 37. Previous studies showed that variants leading to impaired FcγRecIIb activity cause the accumulation of IgGs, B cell apoptosis, and a pro-inflammatory states 38,39. Efforts to pharmacologically modulate FcγRecIIb either directly by regulating immune responses or indirectly by influencing FcγRecIIb interactions through other pathways, using monoclonal antibodies and protein fusion approaches, have produced drugs, such as Obinutuzumab or Rituximab with applications in immune diseases, and hematologic cancers 40,41.

The MR findings were consistent with previous plasma proteome studies that showed that circulating MMP12 levels were linked to cardiovascular outcomes, including heart disease, peripheral artery disease, and stroke 42,43,44,45. Higher genetically-predicted levels of MMP12 have consistently been associated with a lower risk of stroke, and it has been suggested as potential therapeutic target 46. Biologically, MMP12 belongs to a family of endopeptidases that degrade structural components of the extracellular matrix 47. MMP12 plays key pro- and anti-inflammatory roles in the body through the cleavage of cytokines and subsequent regulation of cell migration and signaling, and may contribute to atherosclerotic cardiovascular disease pathogenesis through the regulation of macrophage migration, plaque development, and rupture 47.

Chronic inflammation related to aging has been characterized as a clinical condition, named inflammaging, associated with a high risk of prematurely developing age-related diseases and adverse health outcomes 48,49. This hypothesis agreed with our complementary biomarker analysis that revealed associations between IgG Fc recIIb and lifespan, and MMP12 levels and cardiovascular diseases. Considering that genetic predictions of IgG Fc recIIb and MMP12 levels are also associated with Df, we propose Df as a potential accessible imaging marker of the inflammatory status related to aging, such that a lower Df would be indicative of a higher inflammaging status.

Moreover, reverse MR suggested that genetic variants increasing Df were negatively associated with circulating FOXO3 levels, suggesting that circulating FOXO3 levels might reflect microvascular homeostasis. This is consistent with previous research on FOXO3 that reported its association with human longevity 31, and its critical role in vascular aging 32. FOXO3 is required for maintaining vascular homeostasis under stressful conditions and preventing vascular aging through the regulation of oxidative resistance, apoptosis, autophagy, energy metabolism, and extracellular matrix remodeling processes by targeting the expression of effector genes. Under normal conditions, FOXO3 is inactive due to its negative regulation by the IIS-PI3K-Akt pathway. When cells are exposed to stress, including growth factor deprivation, metabolic stress, and oxidative stress, FOXO3 translocates into the nucleus and exhibits increased transcriptional activity. Dysregulation of FOXO3 contributes to atherosclerosis, vascular calcification, hypertension, and vascular aging-related heart diseases, kidney diseases, and cerebrovascular diseases. Thus, FOXO3 has been considered as a promising therapeutic target for age-related vascular diseases50.

Even though this was the largest genetic study on retinal vascular traits to date, to validate our results and extrapolate them to a valid clinical outcome, it is of utmost importance that new studies include individuals of non-European ancestry. Although we measured 1,159 selected circulating proteins, this still represents a small subset of the ∼20,000 proteins in the human proteome 51. From a methodological perspective, MR relies on several assumptions that cannot all be assessed, although our analyses generally showed concordant effect estimates between different MR approaches. For instance, when assessing the significance of the Egger intercept test, we employed a conservative approach of not correcting for multiple testing; however, our power to detect directional pleiotropy may have been insufficient 52. If undetected directional pleiotropy did not affect the results, the lack of concordance between the MR-Egger estimates and the other MR estimates might be attributable to a violation of an assumption of MR-Egger 53 . We may also have limited power to assess co-localization between variants associated with protein level and Df, leading to the possibility that significant MR findings might reflect the presence of separate causal variants in linkage disequilibrium with one another 54. We measured protein expression levels in plasma, but not in the retina. However, the use of cis-pQTLs, which are likely to be shared across tissues 55, as instrumental variables in these MR analyses, supports the possibility that the MR associations reflect the actions of the proteins of interest in the retina. Additionally, there are little publicly available data for the retinal transcriptome and proteome to perform further enrichment analysis. This lack of available information and rarity of studies is driven by the invasiveness of collecting retinal tissue, and for the complex extraction of proteins and DNA from such samples.

In conclusion, our study identified IgG Fc recIIb and MMP12 as key mediators in immune and inflammation pathways, linking lower Df to a higher risk of cardiometabolic diseases and a shorter lifespan. Therefore, retinal Dfmay be a convenient way to estimate inflammaging, such that lower retinal Df may indicate a higher inflammaging status. Finally, these findings pave the way for new strategies targeting IgG Fc recIIb and MMP12 to promote healthy aging by mitigating age-related immune and inflammatory pathways involved in cardiometabolic diseases and longevity.

Online methods

Study populations

The UK Biobank (https://www.ukbiobank.ac.uk) is a large multi-site cohort study that consists of 502,655 individuals aged between 40 and 69 years at baseline, and recruited from 22 centres across the UK between 2006-2010. The study was approved by the National Research Ethics Committee, reference 11/NW/0382, and informed consent was obtained from all participants as part of the recruitment and assessment process. From these, a baseline questionnaire, physical measurements, and biological samples were undertaken for each participant. Ophthalmic examination was not included in the original baseline assessment and was introduced as an enhancement in six UKBB centres across the UK. This examination consisted in capturing paired retinal fundus with a 45° primary field of view obtained using a Topcon 3D OCT-1000 MKII (Topcon Corporation). These analyses were completed using fundus images collected at the first and the second ophthalmic examination visits from 49,712 participants of white European ancestry with at least one eye image of good quality. The data were processed as published in our previous analysis 10.

Participants from Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS) 56, Genetics of Scottish Health Research Register (GoSHARE) 57 were used for GWAS analysis. GoDARTS is a cohort study in the Tayside region of Scotland that began recruiting participants in 1996 and continued to 2015. The study included 10,149 individuals with type 2 diabetes and 8,157 control subjects without type 2 diabetes at the time of recruitment 56,58. GoSHARE Data on clinical and lifestyle parameters were collected at the time of recruitment, and participants also provided consent to their electronic health record linkage. Retinal photographs used for the Scottish national diabetes retina screening (DRS) are available for all patients with diabetes in GoDARTS. DRS photographs were obtained using a standardized protocol with a 45° view centered on the macula. Participants also provided a sample of blood for genome-wide genotyping that was performed using multiple separate genotyping arrays, including the Affymetrix version 6.0, Illumina OmniExpress BeadChips, Illumina Infinium Broad BeadChips, Illumina Human OmniExpressExome-8 version 1.0 BeadChip, and Illumina OmniExpressExome-8 version 1.2 BeadChip. Genetic data were available for 7,722 T2D participants after quality control. GWAS data were then obtained using the Affymetrix Genome-Wide Human SNP Array 6.0 the Illumina HumanOmniExpress and Broad. The Affymetrix GWAS chip contains 932,979 single nucleotide polymorphisms (SNPs), and the Illumina GWAS chip contains 731,296 SNPs. Then imputation of additional and missing genotypes were performed by SHAPEIT 59 and IMPUTE2 60 using the 1000 Genomes reference panel 61. In addition, 707 Type 2 diabetes cases and 3,478 controls were genotyped using custom genotyping arrays from Illumina. Such arrays include the Immunochip, Cardio-Metabochip (Metabochip), and Human Exome array. The Immunochip contains 196,524 genetic markers from loci that have previously been associated with at least one of 13 autoimmune diseases, including Type 1 diabetes 62, while the Metabochip contains 196□725 SNPs from loci that have prior evidence of associations with T2D, coronary artery disease/myocardial infarction, and 21 related traits 63. The Human Exome Array contains 247,870 genetic markers from across the exome, allowing for studies to focus on identifying protein-altering variants.64 The genotyping process for the GoDARTS and GoSHARE cohorts involved various platforms, including Affymetrix 6.0, Illumina Omni Express-12VI, and GSA v2.0.

After applying quality control criteria, a total of 7,722 participants (6,249 from GoDARTS and 1,473 from GoSHARE) were considered for analysis. The quality control criteria used to exclude individuals from analysis were: Individual genotype call rate < 95%; discrepancy in gender; heterozygosity > 3 standard deviations from the mean; and highly related samples identified through identity by descent analysis. SNP-level quality control was performed by excluding markers with a call rate of less than 95% and those with a Hardy-Weinberg P-Value < 1×10-6. PLINK versions 1.7 and 1.9 were employed for quality control assessment and data preprocessing for imputation. Ancestry outliers were detected using principal component analysis in each cohort. The genotype data from all three cohorts were then imputed against the HRC r1.1 reference panel. Monomorphic markers and those with an imputation quality score below 0.4 were excluded from the post-imputation data 16.

The Canadian Longitudinal Study on Aging (CLSA) is a large, national, stratified, random sample of 50,000 Canadians aged 45 to 85 years at the time of recruitment (2010-2015) and followed until 2033 (or until death). The CLSA aims to investigate the associations between risk factors and the incidence of chronic diseases 65. A subset of 30,000 participants (i.e., comprehensive subset) had physical examinations and biological specimen collection, including fundus photographs (1 for each eye) obtained using the Topcon TRC-NW8 non-mydriatic retinal camera. A total of 50,957 retinal photographs from 25,717 CLSA participants, were analysed using VAMPIRE (Vascular Assessment and Measurement Platform for Images of the Retina, version 3.1, University of Edinburgh and University of Dundee, U.K.) to compute image quality (good/moderate/poor) and the fractal dimension (Df) of the retinal vascular pattern. Participants with poor image quality for both eyes were excluded from subsequent analyses. Among the comprehensive subset, 26,622 CLSA participants (with 93% of Europeans) were successfully genotyped using the UK Biobank Array 66. The quality control steps have been detailed elsewhere 67. Briefly, phasing and imputation were conducted using the TOPMed reference panel at the University of Michigan Imputation Service. We used the TOPMed reference panel version r2, and then pre-phased and imputed the genotype data using EAGLE2 and Minimac, respectively, for both autosomal and X chromosomes. Samples with low call rates (<95%), sex mismatches, or cryptic relatedness were removed. Imputed SNPs were excluded based on low call rates (<95%), deviation from Hardy-Weinberg (p<10-6), low minor allele frequency (MAF<0.0001), and low imputation quality (Rsq < 0.6).

The Prospective Urban Rural Epidemiology (PURE) study is a large prospective study of individuals in 27 low-income, middle-income, and high-income countries. Participant recruitment and selection has been described in detail elsewhere 68. Briefly, the PURE study collected socio-demographics, physical examination, routine laboratory results (e.g., lipid profile), lifestyles, depression and stress questionnaires, disease status and age at diagnosis, medication usage, and family health history at recruitment and each follow-up visit. A biobanking initiative was developed for a subset of PURE participants recruited between January 5, 2005, and December 31, 2006 to assess genomic and proteomic markers of chronic disease risk, based on a case-cohort design. Blood samples from participants were transported from 14 countries (i.e., Argentina, Bangladesh, Brazil, Canada, Chile, Colombia, Iran, Pakistan, Philippines, South Africa, Sweden, Tanzania, United Arab Emirates, and Zimbabwe) to the Population Health Research Institute (Hamilton, ON, Canada) and stored at −165°C. Samples were considered eligible if they belonged to individuals from the major self-reported ethnicity in the residing country (e.g., European ancestry in Sweden). Samples were deemed ineligible if they were unsuitable for analysis or were non-fasting. Hereby, we selected a random sample from the pool of 55,246 eligible participants, and then included all individuals who had incident events of interest that were not selected as part of the random sample. The final sample set included 12,066 PURE participants. The research ethics committees at each study location, including Hamilton Health Sciences, approved the project (Hamilton, ON, Canada). Written informed consent was obtained from each study subject.

Fractal dimension

Retinal fractal dimension (commonly abbreviated as Df) is a measure of vasculature density and branching complexity, as previously described elsewhere 69. Df measurements were obtained after fundus image segmentation with VAMPIRE V3.1 software for each cohort, using validated methods for image pre-processing, vessel segmentation map and Df estimation 9,70,71. The three datasets included participants with both eyes analysed. In the cases of CLSA and UKB, if both images were of a similar good quality, the mean Df was used; otherwise, the image with the highest quality was chosen. For GoDARTS, we included the mean Df if both images were available.

Fundus image quality

Fundus image quality measurement in CLSA was defined through manual evaluation of the vessel segmentation map generated by the VAMPIRE V3.1 software. As for the UKB, this quality evaluation, named image quality score (IQS), was derived from a prior study 72. The software perform automatically detects the retinal vasculature, creating a binary vessel map for each image, thus, following the pipeline described in 10. Images with IQS >0 were classified as good quality and were included in the pipeline. When participants had paired good quality images, the mean Df and the mean image quality score were used for subsequent analysis in the CLSA and UKB datasets. GoDARTs did not include image quality measurements, but retinal images were subject to a manual quality control step during the ophthalmic examination to ensure suitability for phenotype.

GWAS for Fractal Dimension

We established a pipeline to complete the same GWAS across each cohort. The GWAS model was an additive mixed linear model that adjusted for age, sex, fundus image quality score, and the first 10 genetic principal components. Because GoDARTS is a cohort to study diabetes, the GoDARTS GWAS was also adjusted for the presence of diabetic retinopathy. This process was completed using REGENIE software 73, using genotyped SNP data for the first step, and imputed SNP information for the second step.

Meta-analysis

Variants included for the meta-analysis were selected independently in each cohort. Variants were autosomal SNPs present in the genotyping and imputing panel with a Hardy-Weinberg Equilibrium (HWE) >10−6, minor allele frequency (MAF) >5×10−3, call rate >0.9, and imputation score >0.8. The number of total SNPs analysed after quality control was 30,275,286 SNPs in the UKB; 11,950,600 SNPs in the CLSA; and 8,059,472 SNPs in the GoDARTS.

The meta-analysis was completed using a fixed effect inverse variance-based model using METAL software 74. Additionally, we completed a random-effects inverse variance meta-analysis in the significantly heterogenic genetic variants from the fixed-effects meta-analysis using the meta package in R 75. We visualised the effect of SNPs across cohorts using forest plots in the meta package in R 75.

Loci in the meta-analysis were defined using the clump function of PLINK1.9, and UK Biobank European ancestry genotypes as the linkage disequilibrium (LD) reference panel. Clumping parameters were: r2 = 0.1, P = 1×10-6, P2 = 0.01, and kilobase (KB) = 10,000 bp. Associated genes for independent loci were established using the nearest gene strategy. Gene level analyses were conducted by MAGMA software 76.

Genetic correlation

Genomic inflation and genome-wide genetic correlation estimates (rg) for completed GWASs were estimated using the LD Score and HDL software 77,78.

Phenome-wide association studies

Phenome-wide association analysis (PheWAS) was completed to investigate the effects of significant SNPs from the meta-analysis on other traits. To this end, independent lead SNPs were searched in GWAS Catalog 79 and GeneATLAS 80, databases that contain numerous GWAS summary statistics for diverse traits and diseases. Genetic variants must have a P-value less than 1×10-8 on the trait to assume a significant association.

Circulating protein biomarker measurement

A 1.8 mL aliquot of plasma from each PURE participant was processed in the Clinical Research Laboratory and Biobank in Hamilton, ON, Canada. Plasma protein concentrations of 1,159 unique circulating biomarkers were measured using an immunoassay based on proximity extension assay (PEA™) technology (Olink® PEA panels; Uppsala, Sweden, 13 panels of 96 biomarkers each, including CVDII, CVDIII, Metabolism, Inflammation, OncologyII, Cardiometabolic, Organ Damage, Development, Cell Regulation, Immune response, Neurology, OncologyIII, and Neuro Exploratory). The data generated are expressed as relative quantification on the log2 scale of normalized protein expression (NPX™) values. Although NPX values are relative quantification units, the Olink PEA platform has been extensively validated and previous work shows strong relationships between measurements from the multiplex Olink panel and singleplex assays of the same markers with absolute units 82. Individual samples were excluded on the basis of quality controls for immunoassay and detection, as well as the degree of hemolysis 30. NPX values were rank-based normal transformed for further analyses.

Circulating protein level genome-wide association study of 1,159 unique biomarkers

PURE participants suitable for proteomics analyses were directly genotyped for > 800,000 polymorphisms on the Thermofisher Axiom Precision Medicine Research Array (release 3). The genotyping quality control has been described elsewhere 30. Briefly, sample-level quality control checks included assessments of sample completeness (call rate > 0.95), potential sample mix-ups (discrepancies between reported vs. genetically determined sex and/or ethnicity), genetic duplicates, and sample contamination (excess heterozygosity). Samples exhibiting non-ambiguous discrepancies between genetic and self-reported ancestry were removed. Variant-level quality control checks included assessments of variant completeness (call rate > 0.985), plate and batch effects, non-Mendelian segregation within families (Mendelian errors), Hardy Weinberg Equilibrium (HWE) deviations (HWE P-value < 1×10-5), and variant frequency (minor allele frequency > 0.001). After sample and variant quality control procedures, up to 3,514 samples from Europeans and 749,783 variants remained. The average genotyping call rate among passing samples was 0.996535. Analyses were restricted to participants from European, Latin or Persian ancestry as linkage disequilibrium differs between ethnic groups, and thus, might prevent MR assumption violation. We conducted a genome-wide association study analysis (also known as protein Quantitative Trait Loci (pQTLs)), testing the association between each of the 1,159 plasma protein concentration and each of the common genetic variants in 9,150 PURE participants of European, Latin or Persian ancestry, using a linear regression model adjusted for age, sex, and 20 ancestry-specific principal components.

Bidirectional Mendelian randomization and colocalization analyses

To construct the genetic instruments in forward MR, we used cis-protein Quantitative Trait Loci (cis-pQTL) variations that were associated with circulating protein levels (P-Value < 5×10-6), were located up to 200 kb downstream or upstream of the gene that codes for each measured protein, and were independent (pairwise r2 < 0.1). For reverse MR, we used SNPs associated with Df with a P-Value <5×10-8. SNPs were pruned for linkage disequilibrium at a threshold of r2 < 0.1. A total of 35 to 41 SNPs (F-statistics: 31.0 to 31.8) were retained.

As a genetic instrument linked to a protein-altering variant can influence the measurement of the protein binding affinity, genetic variations in the pleiotropic major histocompatibility complex locus, missense and splicing site variants, or variants in linkage disequilibrium with those variants (r2 ≥ 0.9) were excluded in both forward and reverse MR analyses.

For both the forward and reverse MR, we applied the inverse variance weighted IVW method as the primary method. The MR robust adjusted profile scoring (RAPS) method was also performed. A Bonferroni threshold of significance was employed for the MR analysis. MR analyses have been performed using TwoSampleMR and mr.raps R packages.

MR was performed separately in three ethnic groups, European, Persian and Latin, and the results were meta-analyzed using the fixed effect method from the metafor R package rma.uni function. Multivariable Mendelian randomization is a statistical method used to investigate the causal relationship between multiple exposures or risk factors and an outcome of interest 53. In multivariable Mendelian randomization, the aim is to assess the mediating role of intermediate variables in the causal pathway between an exposure and an outcome. To conduct multivariable Mendelian randomization analysis, genetic variants that are associated with both the exposure and/or the intermediate outcomes were used with the MVMR R package 83. Phenome-wide MR used similar methods to those used in forward MR, with genetic instruments being the cis-pQTLs. Genetic associations for outcomes were extracted from publicly available summary statistics of genetic consortia (Suppl. Tables 11, 12).

To determine if the causal variant underlying a significant GWAS association for Df is shared with the biomarker pQTL, colocalization analysis was performed using the Pair-Wise Conditional analysis and Colocalization analysis (PWCoCo) pipeline 84. We excluded the presence of colocalization when the posterior probability that an association existed between a genetic variant and both Df and biomarker concentration (H3+H4) was less than 80% 84. We complemented the colocalization with an additional analysis between pQTL biomarkers and blood single-cell eQTLs from peripheral blood mononuclear cells (PMBCs) generated by the Onek1k resource 33. This step was completed following the Coloc pipeline, which is very similar to that of PWCoCo. Essentially, we extracted those SNPs that colocalized in the GWAS-pQTL analysis, which were then used for an additional colocalization between sc-eQTLs and pQTLs. Causal variants colocalized in expression and proteomic levels if the posterior probability of sharing the causal signal PPH4 > 0.8.

Expression and chromatin activity in retinal tissue

To further support the role of associated Df loci and cis-pQTL biomarkers in retinal tissue, we assessed the evidence of their expression levels and the activity of that genomic region using the Gene Regulatory Networks in Human Retina (Retina GRN)85 and human retinal networks, and enriched annotation from eyeIntegration software 86. Both software programs combine published gene expression data, expression quantitative trait loci (eQTL) information, and chromatin accessibility and loops data, in the case of Retina GRN, from human retinal tissue to derive the regulatory networks.

Protein-protein interaction network analysis of MR biomarkers

We evaluated the biological mechanisms and the interactions between associated MR biomarkers through a protein-protein interaction network study and an enrichment analysis. We used biomarkers that had a P-Value < 0.0001 for each MR analysis in European, European-Latin, or European-Latin-Persian populations to investigate the general processes. STRING 87 and DAVID 88 software were then used to identify the protein-protein interactions of MR biomarkers and their genetic and pathway enrichment. Enriched pathways and functional annotations were considered if FDR and Bonferroni correction were < 0.01.

Data availability

The GWAS meta-analysis results can be download from XXX (DATASHARE, University of Edinburgh) upon publication. The UK Biobank Df calculations can be accessed upon request to UK Biobank resources.

PURE data contain the personal health information of participants from 27 high-, middle-, and low-income countries collected over 20 years. Consent for public disclosure of this information was not obtained at the time of data collection and can no longer be practically collected. Deidentified individual-level genotype and proteomic data for the PURE cohort cannot be shared publicly or through a controlled data repository, but the authors welcome inquiries for collaboration.

Data Availability

All data produced in the present study will be available upon publication

Author contributions

Conceptualization: E.P.C., M.P.

Methodology: A.V.V, N.P., M.C, E.T., J.P., G.P., A.D., E.P.C., M.P.

Software/formal analysis: A.V.V, N.P., Y.H., M.C, E.T., W.N., E.P.C., M.P.

Visualization: A.V.V, N.P., E.P.C., M.P.

Funding acquisition: G.P., M.P. Supervision: G.P., A.D., E.P.C., M.P.

Writing of the original draft: A.V.V, N.P., E.P.C., M.P.

Writing, review and editing: Y.H., M.C., E.T., W.N., J.P., H.G., R.P., S.Y., M.B., A.T., K.R., G.P., A.D.

The authors had full control, and funders played no role in the design, analysis, or interpretation of this work.

All authors have reviewed and approved the final version of the manuscript.

Competing interests

Acknowledgements

This research has been conducted using the UK Biobank Resource under project 788. This research was funded in part by the Medical Research Council grant (MR/N013166/1) to A.V.V. M.O.B. gratefully acknowledges funding from: Foundation Leducq Transatlantic Network of Excellence (17 CVD 03); EPSRC grant no. EP/X025705/1; British Heart Foundation and The Alan Turing Institute Cardiovascular Data Science Award (C-10180357); Diabetes UK (20/0006221); Fight for Sight (5137/5138); the SCONe projects funded by Chief Scientist Office, Edinburgh & Lothians Health Foundation, Sight Scotland, the Royal College of Surgeons of Edinburgh, the RS Macdonald Charitable Trust, and Fight For Sight; the Neurii initiative which is a partnership among Eisai Co., Ltd, Gates Ventures, LifeArc and HDR UK.

This research has been conducted using the CLSA dataset 1906019_McMaster_GPare_Baseline (Baseline Comprehensive (COM) version 4.2), under Application Number 1906019. The CLSA is led by Drs. Parminder Raina, Christina Wolfson and Susan Kirkland. M.P. was supported by the E.J. Moran Campbell Internal Career Research Award from McMaster University, and the Early Career Research Award from Hamilton Health Sciences (HHS). Retinal images analyses of the CLSA were supported by a New Investigator Fund from HHS (NIF-18453 to M.P.), and the Canadian Institutes of Health Research (CIHR) (ACD-170312 and PJT-178302 to M.P.).

The PURE study is an investigator-initiated study funded by the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Ontario, the Ontario Ministry of Health and Long-Term Care, and through unrestricted grants from industry including AstraZeneca, Sanofi-Aventis, Boehringer Ingelheim, Servier, and GalaxoSmithKline. The biomarker project was led by PURE investigators at the Population Health Research Institute (Hamilton, Canada) in collaboration with Bayer scientists. Bayer directly compensated the Population Health Research Institute for measurement of the biomarker panels, and scientific, methodological, and statistical work. Genetic analyses were supported by CIHR (G-18-0022359) and the Heart and Stroke Foundation of Canada (399497) in the form of funding to GP.

References

  1. 1.↵
    The Lancet Public Health, null. Ageing: a 21st century public health challenge? Lancet Public Health 2, e297 (2017).
    OpenUrl
  2. 2.↵
    Lipsitz, L. A. Aging as a Process of Complexity Loss. in Complex Systems Science in Biomedicine (eds. Deisboeck, T. S. & Kresh, J. Y.) 641–654 (Springer US, Boston, MA, 2006). doi:10.1007/978-0-387-33532-2_28.
    OpenUrlCrossRef
  3. 3.↵
    Guo, J. et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Sig Transduct Target Ther 7, 1–40 (2022).
    OpenUrl
  4. 4.↵
    Wu, J.-H. & Liu, T. Y. A. Application of Deep Learning to Retinal-Image-Based Oculomics for Evaluation of Systemic Health: A Review. J Clin Med 12, 152 (2022).
  5. 5.↵
    Zekavat, S. M. et al. Deep Learning of the Retina Enables Phenome-and Genome-Wide Analyses of the Microvasculature. Circulation 145, 134–150 (2022).
    OpenUrlPubMed
  6. 6.↵
    Azemin, M. Z. C. et al. Age-related rarefaction in the fractal dimension of retinal vessel. Neurobiol Aging 33, 194.e1–4 (2012).
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Ong, S. S. et al. Association of fractal dimension and other retinal vascular network parameters with cognitive performance and neuroimaging biomarkers: The Multi-Ethnic Study of Atherosclerosis (MESA). Alzheimers Dement (2023) doi:10.1002/alz.13498.
    OpenUrlCrossRef
  8. 8.↵
    Holmes, M. V., Ala-Korpela, M. & Smith, G. D. Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. Nat Rev Cardiol 14, 577– 590 (2017).
    OpenUrlCrossRefPubMed
  9. 9.↵
    Perez-Rovira, A. et al. VAMPIRE: Vessel assessment and measurement platform for images of the REtina. Conf Proc IEEE Eng Med Biol Soc 2011, 3391–3394 (2011).
    OpenUrlPubMed
  10. 10.↵
    Villaplana-Velasco, A. et al. Fine-mapping of retinal vascular complexity loci identifies Notch regulation as a shared mechanism with myocardial infarction outcomes. Commun Biol 6, 523 (2023).
  11. 11.↵
    Zhao, B. et al. Genome-wide association analysis of 19,629 individuals identifies variants influencing regional brain volumes and refines their genetic co-architecture with cognitive and mental health traits. Nat Genet 51, 1637–1644 (2019).
    OpenUrlCrossRefPubMed
  12. 12.↵
    Sha, Z., Schijven, D., Fisher, S. E. & Francks, C. Genetic architecture of the white matter connectome of the human brain. Sci Adv 9, eadd2870 (2023).
    OpenUrlCrossRef
  13. 13.↵
    Smith, S. M. et al. An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank. Nat Neurosci 24, 737–745 (2021).
    OpenUrl
  14. 14.↵
    Currant, H. et al. Genetic variation affects morphological retinal phenotypes extracted from UK Biobank optical coherence tomography images. PLoS Genet 17, e1009497 (2021).
    OpenUrlPubMed
  15. 15.↵
    Tomasoni, M. et al. Genome-wide Association Studies of Retinal Vessel Tortuosity Identify Numerous Novel Loci Revealing Genes and Pathways Associated With Ocular and Cardiometabolic Diseases. Ophthalmol Sci 3, 100288 (2023).
    OpenUrl
  16. 16.↵
    Veluchamy, A. et al. Association of Genetic Variant at Chromosome 12q23.1 With Neuropathic Pain Susceptibility. JAMA Netw Open 4, e2136560 (2021).
    OpenUrl
  17. 17.↵
    Morgan, M. D. et al. Genome-wide study of hair colour in UK Biobank explains most of the SNP heritability. Nat Commun 9, 5271 (2018).
    OpenUrlCrossRefPubMed
  18. 18.↵
    Lona-Durazo, F. et al. A large Canadian cohort provides insights into the genetic architecture of human hair colour. Commun Biol 4, 1253 (2021).
    OpenUrl
  19. 19.↵
    Eijgelsheim, M. et al. Genome-wide association analysis identifies multiple loci related to resting heart rate. Human Molecular Genetics 19, 3885–3894 (2010).
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    Giri, A. et al. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet 51, 51–62 (2019).
    OpenUrlCrossRefPubMed
  21. 21.↵
    Evangelou, E. et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet 50, 1412–1425 (2018).
    OpenUrlCrossRefPubMed
  22. 22.↵
    van der Harst, P. & Verweij, N. Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease. Circ Res 122, 433–443 (2018).
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Matsumoto, H. et al. HIVEP1 Is a Negative Regulator of NF-κB That Inhibits Systemic Inflammation in Sepsis. Frontiers in Immunology 12, (2021).
  24. 24.↵
    Ellinghaus, D. et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet 48, 510– 518 (2016).
    OpenUrlCrossRefPubMed
  25. 25.↵
    Yordy, J. S. et al. SP100 inhibits ETS1 activity in primary endothelial cells. Oncogene 24, 916–931 (2005).
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Ma, Y. et al. PML Body Component Sp100A Restricts Wild-Type Herpes Simplex Virus 1 Infection. J Virol 96, e0027922 (2022).
    OpenUrl
  27. 27.↵
    Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 53, 1415–1424 (2021).
    OpenUrlCrossRefPubMed
  28. 28.↵
    Temprano-Sagrera, G. et al. Multi-phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations. J Thromb Haemost 20, 1331– 1349 (2022).
    OpenUrlCrossRef
  29. 29.↵
    Leeuw, C. A. de, Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: Generalized Gene-Set Analysis of GWAS Data. PLOS Computational Biology 11, e1004219 (2015).
    OpenUrl
  30. 30.↵
    Narula, S. et al. Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis. The Lancet 396, 968–976 (2020).
    OpenUrl
  31. 31.↵
    Morris, B. J., Willcox, D. C., Donlon, T. A. & Willcox, B. J. FOXO3 – A Major Gene for Human Longevity. Gerontology 61, 515–525 (2015).
    OpenUrlCrossRefPubMed
  32. 32.↵
    Zhao, Y. & Liu, Y.-S. Longevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases. Frontiers in Cardiovascular Medicine 8, (2021).
  33. 33.↵
    Yazar, S. et al. Single-cell eQTL mapping identifies cell type–specific genetic control of autoimmune disease. Science 376, eabf3041 (2022).
    OpenUrlPubMed
  34. 34.↵
    Ratnapriya, R. et al. Retinal transcriptome and eQTL analyses identify genes associated with age-related macular degeneration. Nat Genet 51, 606–610 (2019).
    OpenUrlCrossRef
  35. 35.↵
    Xie, Z. et al. iGWAS: image-based genome-wide association of self-supervised deep phenotyping of human medical images. 2022.05.26.22275626 Preprint at doi:10.1101/2022.05.26.22275626 (2022).
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    Mavromatis, L. A. et al. Multi-omic underpinnings of epigenetic aging and human longevity. Nat Commun 14, 2236 (2023).
    OpenUrl
  37. 37.↵
    Bournazos, S., Gupta, A. & Ravetch, J. V. The role of IgG Fc receptors in antibody-dependent enhancement. Nat Rev Immunol 20, 633–643 (2020).
    OpenUrlCrossRefPubMed
  38. 38.↵
    Smith, K. G. C. & Clatworthy, M. R. FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 10, 328–343 (2010).
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    Simpson, A. P. et al. FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms. Cell Reports 40, 111099 (2022).
    OpenUrl
  40. 40.↵
    Shepard, H. M., Phillips, G. L., Thanos, C. D. & Feldmann, M. Developments in therapy with monoclonal antibodies and related proteins. Clinical Medicine 17, 220–232 (2017).
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    Vaughan, A. T. et al. Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain. J Biol Chem 290, 5424–5437 (2015).
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    Kalani, R. et al. Plasma Proteomic Associations With Incident Ischemic Stroke in Older Adults: The Cardiovascular Health Study. Neurology 100, e2182–e2190 (2023).
    OpenUrl
  43. 43.↵
    Folkersen, L. et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab 2, 1135–1148 (2020).
    OpenUrl
  44. 44.↵
    Henry, A. et al. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization. Circulation 145, 1205–1217 (2022).
    OpenUrl
  45. 45.↵
    Yuan, S. et al. Circulating proteins and peripheral artery disease risk: observational and Mendelian randomization analyses. Eur Heart J Open 3, oead056 (2023).
    OpenUrl
  46. 46.↵
    Chen, L. et al. Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke. Nat Commun 13, 6143 (2022).
    OpenUrlCrossRef
  47. 47.↵
    Veeravalli, K. K. Implications of MMP-12 in the pathophysiology of ischaemic stroke. Stroke Vasc Neurol svn-2023-002363 (2023) doi:10.1136/svn-2023-002363.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat Med 25, 1822–1832 (2019).
    OpenUrlCrossRefPubMed
  49. 49.↵
    Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14, 576–590 (2018).
    OpenUrlCrossRefPubMed
  50. 50.↵
    Calissi, G., Lam, E. W.-F. & Link, W. Therapeutic strategies targeting FOXO transcription factors. Nat Rev Drug Discov 20, 21–38 (2021).
    OpenUrl
  51. 51.↵
    Omenn, G. S. et al. Progress on Identifying and Characterizing the Human Proteome: 2018 Metrics from the HUPO Human Proteome Project. J Proteome Res 17, 4031–4041 (2018).
    OpenUrl
  52. 52.↵
    Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44, 512–525 (2015).
    OpenUrlCrossRefPubMed
  53. 53.↵
    Burgess, S. & Thompson, S. G. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32, 377–389 (2017).
    OpenUrlCrossRefPubMed
  54. 54.↵
    Zheng, J. et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet 52, 1122–1131 (2020).
    OpenUrl
  55. 55.↵
    GTEx Consortium et al. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017).
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    Hébert, H. L. et al. Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS). Int J Epidemiol 47, 380–381j (2018).
    OpenUrlCrossRefPubMed
  57. 57.↵
    McKinstry, B. et al. Cohort profile: the Scottish Research register SHARE. A register of people interested in research participation linked to NHS data sets. BMJ Open 7, e013351 (2017).
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    Mordi, I. R. et al. Prediction of Major Adverse Cardiovascular Events From Retinal, Clinical, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort Study. Diabetes Care 45, 710–716 (2022).
    OpenUrlCrossRefPubMed
  59. 59.↵
    Delaneau, O., Marchini, J. & Zagury, J.-F. A linear complexity phasing method for thousands of genomes. Nat Methods 9, 179–181 (2011).
    OpenUrlCrossRefPubMed
  60. 60.↵
    Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5, e1000529 (2009).
    OpenUrlCrossRefPubMed
  61. 61.↵
    1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
    OpenUrlCrossRefPubMed
  62. 62.↵
    Cortes, A. & Brown, M. A. Promise and pitfalls of the Immunochip. Arthritis Res Ther 13, 101 (2011).
  63. 63.↵
    Voight, B. F. et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 8, e1002793 (2012).
    OpenUrlCrossRefPubMed
  64. 64.↵
    Guo, Y. et al. Illumina human exome genotyping array clustering and quality control. Nat Protoc 9, 2643–2662 (2014).
    OpenUrlCrossRefPubMed
  65. 65.↵
    Raina, P. S. et al. The Canadian longitudinal study on aging (CLSA). Can J Aging 28, 221–229 (2009).
    OpenUrl
  66. 66.↵
    Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
    OpenUrlCrossRefPubMed
  67. 67.↵
    Forgetta, V. et al. Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA). BMJ Open 12, e059021 (2022).
    OpenUrlAbstract/FREE Full Text
  68. 68.↵
    Teo, K. et al. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 158, 1–7.e1 (2009).
    OpenUrlCrossRefPubMedWeb of Science
  69. 69.↵
    Huang, F. et al. Reliability of Using Retinal Vascular Fractal Dimension as a Biomarker in the Diabetic Retinopathy Detection. Journal of Ophthalmology 2016, e6259047 (2016).
    OpenUrl
  70. 70.↵
    MacGillivray, T. J. et al. Suitability of UK Biobank Retinal Images for Automatic Analysis of Morphometric Properties of the Vasculature. PLoS ONE 10, e0127914 (2015).
    OpenUrl
  71. 71.↵
    McGrory, S. et al. Towards Standardization of Quantitative Retinal Vascular Parameters: Comparison of SIVA and VAMPIRE Measurements in the Lothian Birth Cohort 1936. Transl Vis Sci Technol 7, 12 (2018).
  72. 72.↵
    Villaplana Velasco, A., et al. Image quality adjustment can compensate for fractal dimension interocular/intraocular variability and improve disease associations. Investigative Ophthalmology & Visual Science 62, 1791 (2021).
    OpenUrl
  73. 73.↵
    Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat Genet 53, 1097–1103 (2021).
    OpenUrlCrossRefPubMed
  74. 74.↵
    Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
    OpenUrlCrossRefPubMedWeb of Science
  75. 75.↵
    Schwarzer, G., Carpenter, J. R. & Rücker, G. Meta-Analysis with R. (Springer International Publishing, Cham, 2015). doi:10.1007/978-3-319-21416-0.
    OpenUrlCrossRef
  76. 76.↵
    Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun 8, 1826 (2017).
    OpenUrlCrossRefPubMed
  77. 77.↵
    Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nature Genetics 47, 1236–1241 (2015).
    OpenUrlCrossRefPubMed
  78. 78.↵
    Ning, Z., Pawitan, Y. & Shen, X. High-definition likelihood inference of genetic correlations across human complex traits. Nat Genet 52, 859–864 (2020).
    OpenUrl
  79. 79.↵
    Sollis, E. et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res 51, D977–D985 (2023).
    OpenUrlCrossRefPubMed
  80. 80.↵
    Canela-Xandri, O., Rawlik, K. & Tenesa, A. An atlas of genetic associations in UK Biobank. Nat Genet 50, 1593–1599 (2018).
    OpenUrlCrossRefPubMed
  81. 81.
    Canela-Xandri, O., Rawlik, K. & Tenesa, A. An atlas of genetic associations in UK Biobank. Nature Genetics 50, 1593–1599 (2018).
    OpenUrlCrossRefPubMed
  82. 82.↵
    Assarsson, E. et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One 9, e95192 (2014).
    OpenUrlCrossRefPubMed
  83. 83.↵
    Sanderson, E., Spiller, W. & Bowden, J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat Med 40, 5434– 5452 (2021).
    OpenUrlCrossRefPubMed
  84. 84.↵
    Robinson, J. W. et al. An efficient and robust tool for colocalisation: Pair-wise Conditional and Colocalisation (PWCoCo). 2022.08.08.503158 Preprint at doi:10.1101/2022.08.08.503158 (2022).
    OpenUrlAbstract/FREE Full Text
  85. 85.↵
    Marchal, C. et al. High-resolution genome topology of human retina uncovers super enhancer-promoter interactions at tissue-specific and multifactorial disease loci. Nat Commun 13, 5827 (2022).
    OpenUrl
  86. 86.↵
    Bryan, J. M. et al. Identifying core biological processes distinguishing human eye tissues with precise systems-level gene expression analyses and weighted correlation networks. Human Molecular Genetics 27, 3325–3339 (2018).
    OpenUrl
  87. 87.↵
    Szklarczyk, D. et al. The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Research 49, D605–D612 (2021).
    OpenUrlCrossRefPubMed
  88. 88.↵
    Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44–57 (2009).
    OpenUrlCrossRefPubMedWeb of Science
Back to top
Posted July 14, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Proteome-wide Mendelian randomization study implicates inflammaging biomarkers in retinal vasculature, cardiometabolic diseases and longevity
Ana Villaplana-Velasco, Nicolas Perrot, Yu Hang, Michael Chong, Emanuele Trucco, Walter Nelson, Jeremy Petch, Hertzel Gerstein, Raina Parminder, Salim Yusuf, Miguel Bernabeu, Albert Tenesa, Konrad Rawlik, Guillaume Pare, Alexander Doney, Erola Pairo-Castineira, Marie Pigeyre
medRxiv 2024.07.13.24310153; doi: https://doi.org/10.1101/2024.07.13.24310153
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area